{
    "organizations": [],
    "uuid": "6f0629fa9bd66535688da9bc381018160d1c040e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-hebei-changshan-biochemical-pharma/brief-hebei-changshan-biochemical-pharmaceutical-sees-fy-2017-net-profit-up-10-pct-to-30-pct-idUSL3N1PA2PV",
    "ord_in_thread": 0,
    "title": "BRIEF-Hebei Changshan Biochemical Pharmaceutical sees FY 2017 net profit up 10 pct to 30 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15(Reuters) - Hebei Changshan Biochemical Pharmaceutical Co Ltd :\n* Sees FY 2017 net profit to increase by 10 percent to 30 percent, or to be 193.0 million yuan to 228.1 million yuan\n* Says FY 2016 net profit was 175.5 million yuan\n* The reasons for the forecast are increased sales price of raw heparin and improved product sales Source text in Chinese: goo.gl/ZivUj1 Further company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-15T15:21:00.000+02:00",
    "crawled": "2018-01-16T13:34:13.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "hebei",
        "changshan",
        "biochemical",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "fy",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "fy",
        "net",
        "profit",
        "million",
        "yuan",
        "reason",
        "forecast",
        "increased",
        "sale",
        "price",
        "raw",
        "heparin",
        "improved",
        "product",
        "sale",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}